Table 4.

Parameter estimates zero-inflated Poisson models.

	new PVL		new JCL		new SCL		new ITL
	Rate Ratio 95 % KI p-value	Odds Ratio 95 % KI p-value	Rate Ratio 95 % KI p-value	Odds Ratio 95 % KI p-value	Rate Ratio 95 % KI p-value	Odds Ratio 95 % KI p-value	Rate Ratio 95 % KI p-value	Odds Ratio 95 % KI p-value
BL PVL	*1.089 1.064; 1.113 < 0.001	0.932 0.871; 0.996 0.039	*1.042 1.017; 1.068 < 0.001	0.934 0.865; 1.009 0.083	*1.050 1.035; 1.065 < 0.001	0.953 0.895; 1.015 0.136	1.041 0.965; 1.122 0.299	0.984 0.871; 1.111 0.791
BL JCL	1.001 0.990; 1.012 0.83	0.969 0.929; 1.012 0.155	*1.013 1.006; 1.021 < 0.001	0.986 0.953; 1.021 0.426	1.006 1.001; 1.011 0.027	0.990 0.949; 1.033 0.638	0.998 0.961; 1.037 0.921	0.928 0.845; 1.018 0.115
BL SCL	**0.980 0.968; 0.992 0.001	1.030 0.997; 1.065 0.079	1.013 1.001; 1.024 0.029	1.015 0.985; 1.047 0.32	1.007 1.000; 1.014 0.051	0.994 0.967; 1.022 0.663	1.009 0.963; 1.058 0.697	1.093 1.007; 1.186 0.034
BL ITL	0.998 0.955; 1.043 0.943	1.022 0.892; 1.172 0.753	**0.923 0.872; 0.977 0.006	0.956 0.808; 1.130 0.596	**0.961 0.932; 0.991 0.011	0.939 0.812; 1.086 0.395	0.953 0.864; 1.051 0.333	*0.674 0.515; 0.882 0.004
age	0.976 0.965; 0.988 < 0.001	1.045 1.015; 1.075 0.003	0.959 0.945; 0.973 < 0.001	0.986 0.950; 1.024 0.474	0.968 0.960; 0.977 < 0.001	1.005 0.978; 1.033 0.706	0.961 0.921; 1.003 0.065	0.959 0.895; 1.028 0.236
gender (male)	0.873 0.699; 1.089 0.229	1.081 0.603; 1.938 0.795	0.705 0.517; 0.963 0.028	1.267 0.640; 2.509 0.497	0.815 0.681; 0.975 0.025	1.493 0.875; 2.547 0.141	1.534 0.789; 2.982 0.207	1.453 0.504; 4.191 0.489

Significant (after FDR-correction) positive correlations of baseline lesions with new lesions (positive correlation with the number of lesions or negative correlation with the risk of no new lesion) are notified with *. Significant (after FDR-correction) negative correlations of baseline lesions with new lesions (negative correlation with the number of lesions or positive correlation with the risk of no new lesion) are notified with **.